Form 4: Emergent BioSolutions SVP, Products Business, Paul Anthony Williams, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Paul Anthony Williams, SVP, Products Business at Emergent BioSolutions Inc., reports the disposition of 105 shares of common stock to cover tax obligations on February 23, 2024.
Summary
- On February 23, 2024, Paul Anthony Williams, SVP, Products Business at Emergent BioSolutions Inc., disposed of 105 shares of common stock.
- The transaction was executed to cover tax obligations.
- Following the transaction, Williams directly owns 25,469 shares of Emergent BioSolutions Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock transactions by an insider, and does not contain information that would significantly impact sentiment.
Industry Context
This filing is a routine disclosure related to stock transactions by a company insider and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The transaction has minimal impact on stakeholders as it is a small disposition of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of transaction: Disposition of 105 shares of common stock. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.